Clinical efficacy of Reteplase thrombolytic therapy for 100 patients with acute myocardial infarction
Objective To investigate the clinical efficacy of thrombolysis in the treatment of 100 patients with acute myocardial infarction. Methods 100 patients with ST-segment elevation acute myocardial infarction were divided into two groups, including the observation group of 52 cases treated with reteplase thrombolytic therapy and the control group of 48 patients with urokinase for treatment, and the clinical efficacy of the two groups were compared. Results After treatment, the total efficiency of observation group was significantly higher than the control group, recanalization rate of the observation group patients was significantly higher in patients with vascular opened the time is significantly shorter than the control group patients, the differences were statistically significant(P<0.05). Conclusion Reteplase thrombolysis therapy in patients with acute myocardial infarction has good efficacy with short time and mild bleeding, and it is worthy of clinical widely promoted and applied.
NETL
NSTL
万方数据
维普
